Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012

Cancer Vaccines

19 Sep 2012 - 20 Sep 2012 - London, UK

Bookmark and Share

SMi is proud to present their inaugural conference on Cancer Vaccines. This new and exciting event will bring together senior Pharma representatives and key academics to discuss current developments of cancer immunotherapeutics, engineering vaccine adjuvant formulations, advances and challenges in the advancement of novel therapeutic cancer vaccines and much more.


With presentations from industry representatives from the top 50 pharmaceutical companies, this event promises to be a unique platform for networking, and learning from case studies and problem solving.


Key Benefits of Attending:


Consider novel combination therapies in cancer vaccine development

Understand effective process development strategies

Evaluate developments in cell based immunotherapeutics

Discover strategies to improve success and overcome current issues in clinical


Learn about clinical and regulatory design of immunotherapy programs

Hear from the industry on updates on the most recent successful candidates in

Phase III

Develop monitoring immunotherapy outcomes

For more information visit  or contact Lewis Garfield on Text Here

Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Preventing "Friendly Fire" in the Pancreas
Researchers inhibit process that leads to the body attacking its own insulin-producing cells.
3D-Printed Heart-On-A-Chip with Integrated Sensors
Researchers have created the first 3D-printed organ-on-a-chip with integrated sensors, paving the way for more complex, customizable devices.
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Nanomedicine for Breast Cancer Treatment
Using nanoparticles measuring only billionths of a meter in size, doctors are able to deliver drug molecules directly to the affected tissue.
MRSA Uses Decoys to Evade a Last-Resort Antibiotic
Researchers at Imperial College London have discovered that MRSA releases decoy molecules that allow them to escape being killed by the antibiotic.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos